BACKGROUND: Monitoring alcohol use is important in numerous situations. Direct ethanol metabolites, such as ethyl glucuronide (EtG), have been shown to be useful tools in detecting alcohol use and documenting abstinence. For very frequent or continuous control of abstinence, they lack practicability. Therefore, devices measuring ethanol itself might be of interest. This pilot study aims at elucidating the usability and accuracy of the cellular photo digital breathalyzer (CPDB) compared to self-reports in a naturalistic setting. METHOD: 12 social drinkers were included. Subjects used a CPDB 4 times daily, kept diaries of alcohol use and submitted urine for EtG testing over a period of 5 weeks. RESULTS: In total, the 12 subjects reported 84 drinking episodes. 1,609 breath tests were performed and 55 urine EtG tests were collected. Of 84 drinking episodes, CPDB detected 98.8%. The compliance rate for breath testing was 96%. Of the 55 EtG tests submitted, 1 (1.8%) was positive. CONCLUSIONS: The data suggest that the CPDB device holds promise in detecting high, moderate, and low alcohol intake. It seems to have advantages compared to biomarkers and other monitoring devices. The preference for CPDB by the participants might explain the high compliance. Further studies including comparison with biomarkers and transdermal devices are needed.
BACKGROUND: Monitoring alcohol use is important in numerous situations. Direct ethanol metabolites, such as ethyl glucuronide (EtG), have been shown to be useful tools in detecting alcohol use and documenting abstinence. For very frequent or continuous control of abstinence, they lack practicability. Therefore, devices measuring ethanol itself might be of interest. This pilot study aims at elucidating the usability and accuracy of the cellular photo digital breathalyzer (CPDB) compared to self-reports in a naturalistic setting. METHOD: 12 social drinkers were included. Subjects used a CPDB 4 times daily, kept diaries of alcohol use and submitted urine for EtG testing over a period of 5 weeks. RESULTS: In total, the 12 subjects reported 84 drinking episodes. 1,609 breath tests were performed and 55 urine EtG tests were collected. Of 84 drinking episodes, CPDB detected 98.8%. The compliance rate for breath testing was 96%. Of the 55 EtG tests submitted, 1 (1.8%) was positive. CONCLUSIONS: The data suggest that the CPDB device holds promise in detecting high, moderate, and low alcohol intake. It seems to have advantages compared to biomarkers and other monitoring devices. The preference for CPDB by the participants might explain the high compliance. Further studies including comparison with biomarkers and transdermal devices are needed.
Authors: Donald M Dougherty; Sarah L Lake; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Jillian Mullen; John D Roache Journal: Alcohol Clin Exp Res Date: 2015-04 Impact factor: 3.455
Authors: Oladunni Oluwoye; Hailey Reneau; Jalene Herron; Karl C Alcover; Sterling McPherson; John Roll; Michael G McDonell Journal: J Addict Med Date: 2020 May/Jun Impact factor: 4.647
Authors: Alan Gordon; Adi Jaffe; A Thomas McLellan; Gary Richardson; Gregory Skipper; Michel Sucher; Carlos F Tirado; Harold C Urschel Journal: J Addict Med Date: 2017 Mar/Apr Impact factor: 3.702
Authors: Gary M Reisfield; Scott A Teitelbaum; Joseph T Jones; Dana Mason; Max Bleiweis; Ben Lewis Journal: J Anal Toxicol Date: 2021-11-09 Impact factor: 3.367